Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.54%
0%
-12.54%
6 Months
-12.4%
0%
-12.4%
1 Year
5.29%
0%
5.29%
2 Years
-9.75%
0%
-9.75%
3 Years
80.81%
0%
80.81%
4 Years
86.46%
0%
86.46%
5 Years
87.76%
0%
87.76%
Lotus Health Group Co. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
13.02%
EBIT Growth (5y)
42.17%
EBIT to Interest (avg)
14.83
Debt to EBITDA (avg)
0.51
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
0.90
Tax Ratio
26.94%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
15.52%
ROE (avg)
10.21%
Valuation key factors
Factor
Value
P/E Ratio
40
Industry P/E
Price to Book Value
5.74
EV to EBIT
24.91
EV to EBITDA
19.80
EV to Capital Employed
7.70
EV to Sales
3.26
PEG Ratio
0.88
Dividend Yield
NA
ROCE (Latest)
30.93%
ROE (Latest)
14.42%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
822.40
789.10
4.22%
Operating Profit (PBDIT) excl Other Income
116.30
172.60
-32.62%
Interest
8.20
11.30
-27.43%
Exceptional Items
-0.00
1.20
-100.00%
Consolidate Net Profit
55.90
107.10
-47.81%
Operating Profit Margin (Excl OI)
110.90%
186.90%
-7.60%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 4.22% vs 11.50% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -47.81% vs 232.61% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
2,631.00
2,089.90
25.89%
Operating Profit (PBDIT) excl Other Income
381.60
149.70
154.91%
Interest
33.40
1.10
2,936.36%
Exceptional Items
-14.60
39.60
-136.87%
Consolidate Net Profit
199.50
130.70
52.64%
Operating Profit Margin (Excl OI)
117.40%
63.80%
5.36%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 25.89% vs 24.34% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 52.64% vs 178.09% in Dec 2023
About Lotus Health Group Co. 
Lotus Health Group Co.
FMCG
No Details Available.
Company Coordinates 
No Company Details Available






